Abstract
The neurovascular unit (NVU), consisting of endothelial cells, basement membrane, pericytes, astrocytes and microglial cells, couples local neuronal function to local cerebral blood flow and regulates transport of blood-borne molecules across the blood-brain barrier (BBB). The building blocks and the phenotype of the NVU are well-established but the intercellular signaling between the different components remains elusive. A better understanding of the cellular interactions and signaling within the NVU is critical for the development of efficient therapeutics for the treatment of a variety of brain diseases, such as brain cancer, stroke, neuroinflammation and neurodegeneration. This review gives an overview about the current in vivo knowledge of the NVU and the communication between its different cellular constituents. We also discuss the usefulness of various model organisms for studies of the brain vasculature.
Keywords: Astrocyte, basement membrane, blood-brain barrier, endothelial cell, microglia, neurovascular unit, pericyte, transcytosis, endocytosis, Alzheimer's disease
Current Pharmaceutical Design
Title: Getting to Know the Cast - Cellular Interactions and Signaling at the Neurovascular Unit
Volume: 17 Issue: 26
Author(s): Maarja Mae, Annika Armulik and Christer Betsholtz
Affiliation:
Keywords: Astrocyte, basement membrane, blood-brain barrier, endothelial cell, microglia, neurovascular unit, pericyte, transcytosis, endocytosis, Alzheimer's disease
Abstract: The neurovascular unit (NVU), consisting of endothelial cells, basement membrane, pericytes, astrocytes and microglial cells, couples local neuronal function to local cerebral blood flow and regulates transport of blood-borne molecules across the blood-brain barrier (BBB). The building blocks and the phenotype of the NVU are well-established but the intercellular signaling between the different components remains elusive. A better understanding of the cellular interactions and signaling within the NVU is critical for the development of efficient therapeutics for the treatment of a variety of brain diseases, such as brain cancer, stroke, neuroinflammation and neurodegeneration. This review gives an overview about the current in vivo knowledge of the NVU and the communication between its different cellular constituents. We also discuss the usefulness of various model organisms for studies of the brain vasculature.
Export Options
About this article
Cite this article as:
Mae Maarja, Armulik Annika and Betsholtz Christer, Getting to Know the Cast - Cellular Interactions and Signaling at the Neurovascular Unit, Current Pharmaceutical Design 2011; 17 (26) . https://dx.doi.org/10.2174/138161211797440113
DOI https://dx.doi.org/10.2174/138161211797440113 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function
Mini-Reviews in Medicinal Chemistry Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Translational Gap in Glioma Research
Anti-Cancer Agents in Medicinal Chemistry HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Affective Temperaments and Mood Disorders: A Review of Current Knowledge
Current Psychiatry Reviews Adiposity and the Gut - The Role of Gut Hormones
Current Nutrition & Food Science Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus
Current Medicinal Chemistry Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects
Current Stem Cell Research & Therapy Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Current Diabetes Reviews Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach
Current Pharmaceutical Design Neurotoxicity of Insecticides
Current Medicinal Chemistry Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch
Anti-Cancer Agents in Medicinal Chemistry Recent Updates on the Calcium-Sensing Receptor as a Drug Target
Current Medicinal Chemistry Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
Current Pharmaceutical Design Pomegranate Juice does not Affect the Bioavailability of Cyclosporine in Healthy Thai Volunteers
Current Clinical Pharmacology Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Current Vascular Pharmacology Combinatorial Approaches for the Identification of Brain Drug Delivery Targets
Current Pharmaceutical Design The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging